Ligand Pharmaceuticals Incorporated Stock Price and Value Analysis

Should you buy Ligand Pharmaceuticals Incorporated stock? (NasdaqGM:LGND). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Ligand Pharmaceuticals Incorporated to reach your target.

Target type
AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company pays no dividend.

Inside the LGND Numbers

LGND Price
(Ligand Pharmaceuticals Incorporated stock price per share)
$197.96
[?] LGND Fair Price
(based on intrinsic value)
$46.73
[?] LGND Safety Price (based on a variable margin of safety) $30.37
[?] PE Ratio versus Sector 27% higher than other Unknown stocks
[?] PE Ratio versus Industry 55% lower than other Unknown stocks
[?] Cash Yield -0.24%
[?] Free Cash Flow Jitter 107%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,108,765 shares shorted. With 19,256,201 shares available for purchase and an average trading volume over the past 10 trading days of 255,990, it would take at least 4.331 days for all of the short holders to cover their shorts.

Continue Learning: Value Investing Guides

Is Ligand Pharmaceuticals Incorporated Stock on Sale?

We believe that Ligand Pharmaceuticals Incorporated may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Ligand Pharmaceuticals Incorporated looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Advertisement supports free stock analysis content.

Should You Buy LGND Stock?

Does Ligand Pharmaceuticals Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: LGND

This example shows how we apply the Trendshare checklist to LGND: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 197.96
    • Market cap: $3.9B
    • EPS: 2.26
  2. Step 2 — Valuation checks

    • P/E: 87.593
    • FCF yield: -0.1%
    • Date checked: Dec 26, 2025
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.
Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.